---
title: "Tipiracil - Malignant Tumor Of Colon"
sidebar: mydoc_sidebar
permalink: db09343-mesh-d003110-1.html
toc: false 
---


Path ID: `DB09343_MESH_D003110_1`
{% include image.html url="images/db09343-mesh-d003110-1.png" file="db09343-mesh-d003110-1.png" alt="db09343-mesh-d003110-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C000613754 | tipiracil | Drug |
| UniProt:P19971 | Thymidine phosphorylase | Protein |
| GO:0001525 | angiogenesis | BiologicalProcess |
| MESH:D003110 | Malignant tumor of colon | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tipiracil | DECREASES ACTIVITY OF | Thymidine Phosphorylase |
| Thymidine Phosphorylase | POSITIVELY REGULATES | Angiogenesis |
| Angiogenesis | POSITIVELY CORRELATED WITH | Malignant Tumor Of Colon |
|---------|-----------|---------|

Comment: Tipiracil may also play its anti-neoplastic role indirectly when admnistered in combination with Trifluridine (DB:DB00432). In this case, tipiracil will prevent trifluridine breakdown, thus increasing its bioavailability and boosting its systemiic presence (https://en.wikipedia.org/wiki/Trifluridine/tipiracil).

Reference: 
  - [https://go.drugbank.com/drugs/DB09343](https://go.drugbank.com/drugs/DB09343)
